ID   UFD1_CAEEL              Reviewed;         342 AA.
AC   Q19584;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   18-JUN-2025, entry version 145.
DE   RecName: Full=Ubiquitin fusion degradation protein 1 homolog;
DE            Short=UB fusion protein 1;
GN   Name=ufd-1; ORFNames=F19B6.2;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditina; Rhabditomorpha; Rhabditoidea; Rhabditidae; Peloderinae;
OC   Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for investigating
RT   biology.";
RL   Science 282:2012-2018(1998).
RN   [2]
RP   FUNCTION, INTERACTION WITH CDC-48.1; CDC-48.2 AND NPL-4, AND DISRUPTION
RP   PHENOTYPE.
RX   PubMed=16647269; DOI=10.1016/j.jsb.2006.02.015;
RA   Mouysset J., Kaehler C., Hoppe T.;
RT   "A conserved role of Caenorhabditis elegans CDC-48 in ER-associated protein
RT   degradation.";
RL   J. Struct. Biol. 156:41-49(2006).
RN   [3]
RP   FUNCTION, SUBCELLULAR LOCATION, AND DISRUPTION PHENOTYPE.
RX   PubMed=18728180; DOI=10.1073/pnas.0805944105;
RA   Mouysset J., Deichsel A., Moser S., Hoege C., Hyman A.A., Gartner A.,
RA   Hoppe T.;
RT   "Cell cycle progression requires the CDC-48UFD-1/NPL-4 complex for
RT   efficient DNA replication.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:12879-12884(2008).
RN   [4]
RP   IDENTIFICATION IN A COMPLEX WITH UBXN-3; UFD-1 AND NPL-4.1, INTERACTION
RP   WITH CDC-48.1, AND DISRUPTION PHENOTYPE.
RX   PubMed=20977550; DOI=10.1111/j.1365-2443.2010.01454.x;
RA   Sasagawa Y., Yamanaka K., Saito-Sasagawa Y., Ogura T.;
RT   "Caenorhabditis elegans UBX cofactors for CDC-48/p97 control
RT   spermatogenesis.";
RL   Genes Cells 15:1201-1215(2010).
RN   [5]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=21981920; DOI=10.1016/j.molcel.2011.08.028;
RA   Franz A., Orth M., Pirson P.A., Sonneville R., Blow J.J., Gartner A.,
RA   Stemmann O., Hoppe T.;
RT   "CDC-48/p97 coordinates CDT-1 degradation with GINS chromatin dissociation
RT   to ensure faithful DNA replication.";
RL   Mol. Cell 44:85-96(2011).
RN   [6]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=22768338; DOI=10.1371/journal.pone.0040145;
RA   Miedel M.T., Graf N.J., Stephen K.E., Long O.S., Pak S.C., Perlmutter D.H.,
RA   Silverman G.A., Luke C.J.;
RT   "A pro-cathepsin L mutant is a luminal substrate for endoplasmic-reticulum-
RT   associated degradation in C. elegans.";
RL   PLoS ONE 7:E40145-E40145(2012).
RN   [7]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=26842564; DOI=10.1038/ncomms10612;
RA   Franz A., Pirson P.A., Pilger D., Halder S., Achuthankutty D., Kashkar H.,
RA   Ramadan K., Hoppe T.;
RT   "Chromatin-associated degradation is defined by UBXN-3/FAF1 to safeguard
RT   DNA replication fork progression.";
RL   Nat. Commun. 7:10612-10612(2016).
CC   -!- FUNCTION: Functions at a post-ubiquitination step in the ubiquitin
CC       fusion degradation (UFD) pathway (By similarity). In association with
CC       npl-4.1 and/or npl-4.2 and ATPase cdc-48.1 and/or cdc-48.2, involved in
CC       the cytoplasmic elimination of misfolded proteins exported from the ER
CC       (PubMed:16647269, PubMed:22768338). This pathway, known as ERAD,
CC       prevents the activation of the unfolded protein response (UPR) caused
CC       by the accumulation of misfolded proteins in the ER (PubMed:16647269,
CC       PubMed:22768338). During S phase and in association with npl-4.1 and/or
CC       npl-4.2, cdc-48.1 and/or cdc-48.2 and ubxn-3, ensures the degradation
CC       of DNA licensing factor cdt-1 after the initiation of DNA replication
CC       and thus the disassembly of the DNA replication CMG helicase complex by
CC       promoting the dissociation from chromatin of several of its components
CC       including cdc-45 and sld-5 (PubMed:18728180, PubMed:21981920,
CC       PubMed:26842564). Regulates ubxn-3 nuclear localization during S phase
CC       (PubMed:26842564). {ECO:0000250|UniProtKB:P53044,
CC       ECO:0000269|PubMed:16647269, ECO:0000269|PubMed:18728180,
CC       ECO:0000269|PubMed:21981920, ECO:0000269|PubMed:22768338,
CC       ECO:0000269|PubMed:26842564}.
CC   -!- SUBUNIT: Forms a complex composed of ubxn-3, ufd-1, npl-4.1 and
CC       cdc-48.1; within the complex interacts with cdc-48.1 (PubMed:16647269,
CC       PubMed:20977550). Interacts with cdc-48.2 (PubMed:16647269). Interacts
CC       with npl-4.1 and/or npl-4.2 (PubMed:16647269).
CC       {ECO:0000269|PubMed:16647269, ECO:0000269|PubMed:20977550}.
CC   -!- INTERACTION:
CC       Q19584; Q95QZ9: npl-4.2; NbExp=3; IntAct=EBI-319945, EBI-319957;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:18728180}. Nucleus
CC       {ECO:0000269|PubMed:18728180}. Note=Localizes to the cytoplasm during
CC       mitosis. Nuclear localization upon nuclear membrane re-assembly is cdc-
CC       48-dependent. {ECO:0000269|PubMed:18728180}.
CC   -!- DISRUPTION PHENOTYPE: RNAi-mediated knockdown causes embryonic
CC       lethality (PubMed:16647269, PubMed:18728180). In embryos, DNA
CC       replication is partially impaired causing a delay in S phase
CC       progression in P0, AB and P1 cells; simultaneous RNAi-mediated
CC       knockdown of DNA replication checkpoint kinases chk-1 or atl-1
CC       suppresses the delay in S phase (PubMed:18728180). Prevents DNA
CC       replication licensing factor cdt-1 down-regulation and causes cdt-1
CC       accumulation on mitotic chromosomes (PubMed:21981920). Impairs
CC       dissociation from the chromatin of components of the DNA replication
CC       machinery, including cdc-45 and GINS complex component sld-5, resulting
CC       in their persistent association with chromatin throughout embryonic
CC       mitosis (PubMed:18728180, PubMed:21981920, PubMed:26842564). Abnormal
CC       ubxn-3 localization into punctate structures in the nucleus
CC       (PubMed:26842564). Reduces npl-4 expression in embryos
CC       (PubMed:21981920, PubMed:26842564). RNAi-mediated knockdown in adults
CC       causes defects in germline development, induces the unfolded protein
CC       response, and causes the accumulation of misfolded protein cpl-1 in the
CC       ER (PubMed:16647269, PubMed:20977550, PubMed:22768338).
CC       {ECO:0000269|PubMed:16647269, ECO:0000269|PubMed:18728180,
CC       ECO:0000269|PubMed:20977550, ECO:0000269|PubMed:21981920,
CC       ECO:0000269|PubMed:22768338, ECO:0000269|PubMed:26842564}.
CC   -!- SIMILARITY: Belongs to the UFD1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z69635; CAA93460.1; -; Genomic_DNA.
DR   PIR; T21108; T21108.
DR   RefSeq; NP_502348.1; NM_069947.5.
DR   AlphaFoldDB; Q19584; -.
DR   SMR; Q19584; -.
DR   BioGRID; 533178; 7.
DR   DIP; DIP-26847N; -.
DR   FunCoup; Q19584; 3401.
DR   IntAct; Q19584; 3.
DR   STRING; 6239.F19B6.2a.2; -.
DR   iPTMnet; Q19584; -.
DR   PaxDb; 6239-F19B6.2a; -.
DR   PeptideAtlas; Q19584; -.
DR   EnsemblMetazoa; F19B6.2a.1; F19B6.2a.1; WBGene00006733.
DR   GeneID; 3565860; -.
DR   KEGG; cel:CELE_F19B6.2; -.
DR   UCSC; F19B6.2b; c. elegans.
DR   AGR; WB:WBGene00006733; -.
DR   CTD; 3565860; -.
DR   WormBase; F19B6.2a; CE05667; WBGene00006733; ufd-1.
DR   eggNOG; KOG1816; Eukaryota.
DR   InParanoid; Q19584; -.
DR   OMA; WMMQQLC; -.
DR   OrthoDB; 422728at2759; -.
DR   PhylomeDB; Q19584; -.
DR   Reactome; R-CEL-110320; Translesion Synthesis by POLH.
DR   Reactome; R-CEL-8951664; Neddylation.
DR   Reactome; R-CEL-9755511; KEAP1-NFE2L2 pathway.
DR   PRO; PR:Q19584; -.
DR   Proteomes; UP000001940; Chromosome IV.
DR   Bgee; WBGene00006733; Expressed in germ line (C elegans) and 4 other cell types or tissues.
DR   ExpressionAtlas; Q19584; baseline and differential.
DR   GO; GO:0005634; C:nucleus; IDA:WormBase.
DR   GO; GO:0034098; C:VCP-NPL4-UFD1 AAA ATPase complex; IDA:UniProtKB.
DR   GO; GO:0031593; F:polyubiquitin modification-dependent protein binding; IBA:GO_Central.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:UniProtKB.
DR   GO; GO:0009792; P:embryo development ending in birth or egg hatching; IMP:WormBase.
DR   GO; GO:0036503; P:ERAD pathway; IMP:WormBase.
DR   GO; GO:1900182; P:positive regulation of protein localization to nucleus; IMP:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro.
DR   FunFam; 2.40.40.50:FF:000001; Ubiquitin fusion degradation protein 1 homolog; 1.
DR   FunFam; 3.10.330.10:FF:000002; ubiquitin fusion degradation protein 1 homolog; 1.
DR   Gene3D; 3.10.330.10; -; 1.
DR   Gene3D; 2.40.40.50; Ubiquitin fusion degradation protein UFD1, N-terminal domain; 1.
DR   InterPro; IPR004854; Ufd1-like.
DR   InterPro; IPR042299; Ufd1-like_Nn.
DR   InterPro; IPR055417; UFD1_N1.
DR   InterPro; IPR055418; UFD1_N2.
DR   PANTHER; PTHR12555; UBIQUITIN FUSION DEGRADATON PROTEIN 1; 1.
DR   PANTHER; PTHR12555:SF13; UBIQUITIN RECOGNITION FACTOR IN ER-ASSOCIATED DEGRADATION PROTEIN 1; 1.
DR   Pfam; PF03152; UFD1_N1; 1.
DR   Pfam; PF24842; UFD1_N2; 1.
PE   1: Evidence at protein level;
KW   Cytoplasm; Nucleus; Reference proteome; Ubl conjugation pathway.
FT   CHAIN           1..342
FT                   /note="Ubiquitin fusion degradation protein 1 homolog"
FT                   /id="PRO_0000194986"
FT   REGION          245..276
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          318..342
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        259..275
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   342 AA;  36904 MW;  4D809C9DE97C0F15 CRC64;
     MQAWIQQGLH GMQMGGRVGN YDQTFVVYGP VFLPNATQSK ISEINYGGKI LLPSSALNLL
     MQYNIPMPML FKLTNMAVQR VTHCGVLEFS APEGQAILPL WMMQQLGLDD GDTIRIESAT
     LPKATFAKLK PMSLEFLNIT NPKAVLEVEL RKYACLTKND RIPTSYAGQT LEFLVVDLKP
     ANSVCIIECD VNLDFDPPEG YVEQPRQVTP AVTAKPPAPD ASAFIGAGQK AGGSGGTGQN
     ATSVFGGAGR RLDGKKKPSS SVSLSDGTGV STSNAAPVAN DLPAIPPVVV NEDYKPGRVS
     FLRYDYKRVD VLEKELREKE ASKAGQPSNV FRGGNRTLRG AR
//
